Article Information
History
- January 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lindsey Wang1,2,
- Nathan A. Berger2,3,
- David C. Kaelber4,
- Pamela B. Davis5,
- Nora D. Volkow6 and
- Rong Xu1,3,*
- 1Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, OH, USA
- 2Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, OH, USA
- 3Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
- 4The Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, OH, USA
- 5Center for Community Health Integration, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
- 6National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA
- ↵*Corresponding Author: Rong Xu, PhD, Center for Artificial Intelligence in Drug Discovery, 2103 Cornell Rd, Cleveland, OH 44106, Email: rxx{at}case.edu, Phone: 216-3680023
Posted January 02, 2022.
Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron
